We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Lab Information Systems Sector Reaches 1 Billion

By LabMedica International staff writers
Posted on 30 Dec 1899
The global laboratory information systems (LIS) sector reached USD 1 billion in 2015, in part due to the expected rebound of independent labs, according to a new healthcare market report on LIS.

The new report, “World Market for Laboratory Information Systems” by Kalorama Information (New York, NY, USA), focuses on the market for LIS (also known as LIMS – laboratory information management systems) in clinical diagnostic healthcare and pharmaceutical drug discovery laboratories, although other drug research & development labs are included.

After seeing business contract by nearly 5% over the past 5 years, independent labs are projected by Kalorama to realize new growth from expected increases from previously uninsured patients. More...


One of the main motivators for harnessing automation in laboratories involves increasing productivity by minimizing non-value-added steps, including such processes as sorting tubes, decapping, centrifugation, loading analyzers, and prepping & sorting materials for storage. Non-value-added steps usually can be addressed by automated systems. Many LIS offer modular-based systems with customizable functionality, scalability, and a high level of adaptable connectivity for access to EMRs.

Labs “anticipate much from their LIS, including an ability to connect virtually all lab instrumentation, perform automated data collection, and track workflow,” said Bruce Carlson, publisher of Kalorama Information, adding that installation of a LIS has “potential to increase a laboratory's productivity in the range of 40%-50% over time.”

Kalorama thinks there is a need for LIS in drug discovery and early-stage development to provide global access and enterprise visibility for cross-functional groups to leverage work already done and increase operating efficiency. Seamless enterprise-wide integration is a necessity as it makes key knowledge originating in the laboratory available to management in real-time. Integrating instrumentation and laboratories at different locations facilitates better data correlation and collaboration, end-to-end report generation, and more-secure data exchanges. Many believe that the LIS will become a central system for integrating all the data as the system is often the data management work horse, as well as a component of broader integration efforts.

Kalorama’s report provides full market coverage, including key facts about diagnostic labs; growth (1997–2014, and estimated 2015); world LIS market (2015–2020) for clinical, NGS, and drug discovery labs; major pharmaceutical companies, number of potential lab sites for LIS (2015); selected vendors; sites operating LIS; recent key vendor mergers & acquisitions; and more.

This report generally forecasts future growth to 2020. Market segments covered include North American, European, Brazilian, Chinese, and Japanese markets, as well as segments for LIS software, hardware, and implementation services.

Related Links:

Kalorama Information
World Market for Laboratory Information Systems, report



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
New
Automated PCR Setup
ESTREAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.